arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Actinium Pharmaceuticals, Inc.

ATNM Health Care Biotechnology: Pharmaceutical Preparations
$1.50
▲ +8.8% Today
as of Oct 23, 11:15 ET
Last 30 days +17.97% Sep 14 → Oct 23
$0.93 $1.11 $1.29 $1.47 $1.65 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.33
High
$1.66
Low
$1.36
Volume
$826,022
Avg Vol
$172,101
Mkt Cap
$36M
P/E (TTM)
2.05
Beta
—
52w High
$1.74
52w Low
$0.73
Div Yield
—
Shares Out
$31M

Recent Press Releases & News last 60 days · 12 items

Oct 23 · 12:00 PR PR Newswire
Actinium Pharmaceuticals to Highlight First-in-Human Phase 1 Study of ATNM-400 a HER3-Targeted Non-PSMA Radiotherapy in Prostate Cancer at ESMO 2026
Oct 20 · 12:00 PR PR Newswire
Actinium Pharmaceuticals Unveils ATNM‑400 Data at EANM 2026 with a First‑In‑Human HER3‑Targeted Radiotherapy Approach Beyond PSMA in Prostate Cancer
Oct 20 · 11:30 PR PR Newswire
Actinium Pharmaceuticals Presents EANM 2026 Results Reinforcing ATNM-400's Pan-Tumor Potential Across Lung, Colorectal and Ovarian Cancer Models
▸ Show all 12 press releases & news Free account →

ATNM earnings at a glance

The options market is pricing a move of about ±254.6% after the report, a range of roughly -$2.32 to $5.32 from today's $1.50. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±5.4% on average; after the most recent report on May 8, 2026 it moved +7.4%. That means options currently expect more movement than ATNM has typically delivered. ATNM beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 22%. The share price of $1.50 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.73
$1.74
76% of range
Avg surprise (last 4)
-2.7%
Avg reaction (last 2)
+5.4%
100% positive
Latest IV / EM
2156%
EM ±254.6% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.58$-0.21$0.16$0.52$0.89 Actual $-0.43Actual $-0.58Actual $-0.49Actual $-0.31Actual $-0.38Actual $-0.37Actual $-0.51Est $-0.26Actual $-0.22Est $-0.32Actual $-0.16Est $-0.25Actual $-0.18Est $-0.22Actual $0.89 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-16M$-3M$10M$24M$37M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.89 — — — — financials
Fri May 8, 2026Mar/2026 $-0.18 $-0.22 +18.2% +64.7% +7.4% earnings
Fri Nov 14, 2025Sep/2025 $-0.16 $-0.25 +36.0% — — earnings
Fri Aug 8, 2025Jun/2025 $-0.22 $-0.32 +31.2% — — earnings
Fri May 9, 2025Mar/2025 $-0.51 $-0.26 -96.2% — +3.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.37 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.38 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.31 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.49 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.58 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.43 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$35M——$90,000————
Cost of revenue————————
Gross profit————————
Operating income$28M$-6M—$-6M$-8M$-17M—$-13M
Net income$28M$-6M—$-5M$-7M$-16M—$-12M
EPS (diluted)$0.89$-0.18—$-0.16$-0.22$-0.51—$-0.37

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$36M$42M$48M$53M$60M$65M$73M$79M
Inventory————————
Total current assets$38M$43M$49M$54M$61M$66M$75M$80M
Total assets$40M$45M$52M$56M$63M$69M$77M$82M
Long-term debt————————
Total liabilities$10M$43M$44M$42M$44M$43M$44M$44M
Total equity$30M$2M$8M$14M$19M$26M$33M$38M

Implied volatility — last 90 days

710%2684%4659%6634%8609% Jun 07 — IV 1905% · EM ±263.9%Jun 08 — IV 2000% · EM ±264.2%Jun 09 — IV 2292% · EM ±287.1%Jun 10 — IV 2419% · EM ±285.7%Jun 11 — IV 2567% · EM ±283.7%Jun 12 — IV 2807% · EM ±287.1%Jun 15 — IV 4078% · EM ±295.0%Jun 16 — IV 5097% · EM ±301.0%Jun 17 — IV 6808% · EM ±284.3%Jun 19 — IV 769% · EM ±169.9%Jun 22 — IV 1372% · EM ±286.4%Jun 23 — IV 1438% · EM ±294.1%Jun 24 — IV 1458% · EM ±292.1%Jun 25 — IV 1827% · EM ±357.9%Jun 26 — IV 1610% · EM ±308.1%Jun 29 — IV 1739% · EM ±308.1%Jun 30 — IV 1807% · EM ±311.2%Jul 01 — IV 1863% · EM ±311.3%Jul 02 — IV 1922% · EM ±310.9%Jul 03 — IV 1990% · EM ±310.9%Jul 06 — IV 2254% · EM ±312.2%Jul 07 — IV 2236% · EM ±295.2%Jul 08 — IV 2427% · EM ±304.1%Jul 09 — IV 2618% · EM ±309.3%Jul 10 — IV 2919% · EM ±322.6%Jul 13 — IV 4101% · EM ±342.5%Jul 14 — IV 4942% · EM ±357.5%Jul 15 — IV 5798% · EM ±342.4%Jul 16 — IV 8609% · EM ±359.6%Jul 20 — IV 1510% · EM ±356.7%Jul 21 — IV 1529% · EM ±355.6%Jul 22 — IV 1894% · EM ±433.3%Jul 23 — IV 1946% · EM ±437.7%Jul 24 — IV 2078% · EM ±459.3%Jul 27 — IV 2242% · EM ±468.2%Jul 28 — IV 2228% · EM ±455.9%Jul 29 — IV 2386% · EM ±478.0%Jul 30 — IV 2440% · EM ±477.9%Jul 31 — IV 2497% · EM ±478.0%Aug 03 — IV 2817% · EM ±499.1%Aug 04 — IV 2904% · EM ±500.0%Aug 05 — IV 2758% · EM ±460.8%Aug 06 — IV 3209% · EM ±519.1%Aug 07 — IV 3290% · EM ±514.2%Aug 10 — IV 3187% · EM ±441.4%Aug 11 — IV 3294% · EM ±435.0%Aug 12 — IV 3256% · EM ±408.0%Aug 13 — IV 2854% · EM ±337.2%Aug 14 — IV 2741% · EM ±302.9%Aug 17 — IV 3250% · EM ±271.4%Aug 18 — IV 3818% · EM ±276.2%Aug 19 — IV 4195% · EM ±247.8%Aug 20 — IV 5986% · EM ±250.0%Aug 24 — IV 1300% · EM ±271.4%Aug 25 — IV 1290% · EM ±263.9%Aug 26 — IV 1409% · EM ±282.2%Aug 27 — IV 1557% · EM ±305.0%Aug 28 — IV 1526% · EM ±292.1%Aug 31 — IV 1632% · EM ±289.2%Sep 01 — IV 1779% · EM ±306.4%Sep 02 — IV 1766% · EM ±295.0%Sep 03 — IV 1737% · EM ±281.0%Sep 04 — IV 1833% · EM ±286.4%Sep 07 — IV 2068% · EM ±286.4%Sep 08 — IV 1570% · EM ±207.3%Sep 16 — IV 4574% · EM ±270.2%Sep 17 — IV 5232% · EM ±218.5%Sep 21 — IV 938% · EM ±195.8%Sep 22 — IV 710% · EM ±145.3%Sep 23 — IV 994% · EM ±199.2%Sep 24 — IV 1137% · EM ±222.7%Sep 25 — IV 1459% · EM ±279.2%Sep 28 — IV 1315% · EM ±233.1%Sep 29 — IV 1350% · EM ±232.5%Sep 30 — IV 1470% · EM ±245.5%Oct 01 — IV 1478% · EM ±239.1%Oct 02 — IV 1887% · EM ±294.9%Oct 06 — IV 1740% · EM ±229.7%Oct 07 — IV 2201% · EM ±275.7%Oct 08 — IV 2156% · EM ±254.6%

Sector peers

BCTX
BriaCell Therapeutics Corp.
$35M $3.38-6.1%
RMTI
Rockwell Medical, Inc.
$35M $7.16+1.1%
IBO
Impact BioMedical, Inc.
$38M $3.66-9.0%
NSRX
Nasus Pharma Ltd.
$40M $3.36+9.9%
VYNE
VYNE Therapeutics Inc.
$31M $28.56
MIRA
MIRA Pharmaceuticals, Inc.
$30M $0.62-9.0%

ATNM earnings FAQ

What is ATNM's expected move for earnings?

Options currently price a move of about ±254.6%, or $3.82 per share either way from $1.50.

How does ATNM stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.4%, up 2 times and down 0 times.

What is ATNM's implied volatility?

ATNM's at-the-money implied volatility is about 22% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in